Oncology Potential Use of Bispecific Antibodies Designed to Target CD20 on B Cells and CD3 on T Cells clinical topic updates By Julie M. Vose, MD, MBA, FASCO
Oncology Potential Role of BCL-2 Inhibition in the Treatment of Mantle Cell Lymphoma clinical topic updates By Brad Kahl, MD
Oncology Immunomodulator-Based Triplet Therapy in Patients With Relapsed/Refractory Multiple Myeloma clinical topic updates By Carol Ann Huff, MD
Oncology Treatment Protocols for Patients With Multiple Myeloma Who Relapse After Transplant clinical topic updates By James R. Berenson, MD
Oncology In the Crosshairs: Hormone-Sensitive Oligometastatic Disease clinical topic updates By Glen Gejerman, MD